Results 81 to 90 of about 10,576 (193)

De Novo Heart Failure in a 32‐Year‐Old Man From Congenital Ostial Left Main Coronary Atresia

CJC Pediatric &Congenital Heart Disease, Volume 5, Issue 3, Page 185-188, June 2026.
Gary Wang, Taylor Petropoulos, Osami Honjo, Rafael Alonso‐Gonzalez, Adriana Luk, Filio Billia   +5 more
wiley   +1 more source

Combination perindopril/indapamide for the treatment of hypertension: A review

, 2011
Introduction: Hypertension is an important risk factor for cardiovascular complications and the need to treat this condition has been well established. Despite the availability of many antihypertensive drugs, it is often necessary to combine several of ...
de Leeuw, Peter W., Peter W de Leeuw
core   +1 more source

Perindopril for improving cardiovascular events

Vascular Health and Risk Management, 2014
James J DiNicolantonio, James H O'Keefe Department of Preventive Cardiology, Saint Luke's Mid America Heart Institute, Kansas City, MO, USAIn a recent review in Vascular Health and Risk Management Wang et al state that “In mainly placebo ...
DiNicolantonio JJ, O’Keefe JH
doaj  

Perindopril and beta-blocker for the prevention of cardiac events and mortality in stable coronary artery disease patients: A EUropean trial on Reduction Of cardiac events with Perindopril in stable coronary Artery disease (EUROPA) subanalysis

, 2015
Background beta-Blockers relieve angina/ischemia in stable coronary artery disease (CAD), and angiotensin-converting enzyme inhibitors prevent CAD outcomes.
Fox, Kim M., Remme, WJ, Simoons, Maarten, Remme, Willem J., Fox, KM, Ferrari, R, Simoons, Maarten L., FERRARI, Roberto, Bertrand, ME, Bertrand, Michel E   +9 more
core   +1 more source

Comparison of perindopril versus captopril for treatment of acute myocardial infarction

, 2002
Angiotensin-converting enzyme (ACE) inhibitors reduce mortality in patients with acute myocardial infarction (AMI), but these benefits might be limited by acute hemodynamic changes and difficulties in titrating to recommended doses. The objective of this
Ng, W, Chen, WH, Lau, YK, Tse, HF, Leung, SK, Lau, CP, Li, SK, Chan, KK, Keung, KK, Tang, YW   +9 more
core   +1 more source

Fixed low-dose perindopril-indapamide combination in hypertensive patients with chronic renal failure

, 1998
The angiotensin converting enzyme inhibitor perindopril and the diuretic indapamide have been shown to be effective antihypertensive agents in patients with chronic renal failure.
M DRATWA, Dratwa, Max, A MEYRIER, Sennesael, J., Lachaud-Pettiti, Valérie, Meyrier, Alain, J SENNESAEL, V LACHAUDPETTITI   +7 more
core   +1 more source

Oxygen support of physical stress in perindopril-treated hypertensive patients [PDF]

, 2005
Aim. To study and assess, with spiroergometry method, main parameters of physical stress (PS) oxygen (O2) support in arterial hypertension (AH) patients receiving combined and monotherapy with an ACE inhibitor perindopril. Material and methods. The study
T. N. Apanasenko, V. I. Makolkin, Sh. Z. Zambakhidze, D. A. Napalkov   +3 more
core  

Angiotensin-converting enzyme inhibition in cardiovascular disease: evidence with perindopril

, 2005
Perindopril isa long-acting, once-daily lipophilic anglotensln-converting enzyme Inhlbltor with high tissue angiotensln-converting enzyme afflnity, lowering angiotensin Il and potentiating bradyklnln.
FERRARI, Roberto, Roberto Ferrari
core   +1 more source

DEVELOPMENT AND VALIDATION OF STABILITY-INDICATING HPTLC METHOD FOR THE ESTIMATION OF PERINDOPRIL AND INDAPAMIDE [PDF]

, 2014
Objective: To develop a validated stability indicating HPTLC method for determination Perindopril and Indapamide. Methods: The method was based on the separation of two drugs on plates precoated with silica gel 60 F254 using Dichloromethane: Methanol ...
Hibare, Viraj, Bhoir, Varsha, Damle, Mrinalini C.   +2 more
core   +1 more source

Arterial hypertension and thyroid function compensation: pharmacotherapy aspects

Кардиоваскулярная терапия и профилактика, 2008
Based on literature data on arterial hypertension (AH) therapy in hypothyrosis patients, a need for investigating this issue considering pathogenesis of hypothyrosis-specific hemodynamic changes, is emphasized.
G. B. Selivanova
doaj